(Q40286820)

English

Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression

scientific article published on 27 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Meena R Sharma

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lauren Koltowski

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Robert T Ownbey

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

George P Tuszynski

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mahesh C Sharma

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

27 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

81

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

146-156

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

The fibrinolytic system in neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Functional evaluation of plasmin formation in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Specific down-regulation of annexin II expression in human cells interferes with cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Proteases and protease inhibitors in tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Plasmin-activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Urokinase-type plasminogen activator antigen and early relapse in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Purification and characterization of constituent testosterone 2 alpha-hydroxylase (cytochrome P450(2)alpha) from mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Interactions of gender, growth hormone, and phenobarbital induction on murine Cyp2b expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Angiostatin generation by human tumor cell lines: involvement of plasminogen activators.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.03.003

7 January 2021

Identifiers

10.1016/J.YEXMP.2006.03.003

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40286820&oldid=2205437327"